Skip to content

The expansion of the fourth industrial revolution is being defined by innovation at the level of the byte, the atom and the gene. This quarter, we take note of four innovations that manipulate these basic building blocks to improve life as we know it, ranging from the way we hear to the way we heal. The human capacity for technological ingenuity continues to impress us.  

Personalized cell robot repairs a scratch in a layer of neurons

Researchers from Tufts University have developed an “anthrobot” made of cells that is able to repair damaged human tissue. The anthrobot was grown out of human tracheal (windpipe) skin cells that were placed in gel for two weeks and then transferred to a less viscous solution. The result was a collection of mobile cells with the ability to “row” through the environment using their exterior cilia—hairlike structures that encompass their surfaces. Most remarkably, several anthrobots fused to form a “superbot” that then healed a sheet of scratched neurons within three days without any genetic modification.1

Why it matters: The anthrobot may inaugurate a new era in healing, referred to by insiders as “tissue engineering 2.0.” Anthrobots will likely be made from a person’s own tissue and then used to clear arteries, break up mucus or deliver drugs. In the future, scientists may be able to develop biobots with applications in fields as diverse as sustainable construction and outer-space exploration.

Exhibit 1: Anthrobots

Anthrobots, which today have the potential to heal at the cellular level, will likely be made from a person's own tissue

For illustrative purposes only.

New AI-powered jet responds to the autonomous drone threat

A cheap and autonomous vertical takeoff and landing jet has been successfully designed. It was built as a countermeasure to modern military drones that can be produced at high volume and low cost. When faced with a threat, the jet uses artificial intelligence (AI) to image the threat and decide whether to engage. Perhaps most importantly, the jet is reusable, a feature that dramatically reduces the lifetime cost of using the weapon.2

Why it matters: Geopolitical tensions are on the rise, evidenced by recent conflicts in Ukraine and the Middle East and increasing tensions over the South China Sea. The rise of AI allows countries around the world to deploy sophisticated autonomous drones at low cost, a development that leaves the defenses of many modern militaries structurally ill-prepared. This jet is an important new option to address this emerging threat. 

Scientists edit the genes of the cow microbiome to fight climate change

Using clustered regularly interspaced short palindromic repeats (commonly known as CRISPR), scientists have found a way to edit the genes of methane-producing bacteria found in the stomachs of cows. Cows will swallow the treatment, potentially using lipid nanoparticles as a method of delivery. Once inside the cow, the gene edit “gifts” a member of the microbiome community with a genetic advantage, allowing it to proliferate until the entire community has the edit.3 

Why it matters: Methane accounts for 16% of global emissions and is 28x more potent than carbon dioxide at trapping heat in the atmosphere.4 Cows are responsible for 30% of all global methane emissions.“Turning off” the methane-producing mechanism in these bacteria could contribute sizably to overall emissions reductions.

Hearing aids filter background noise with AI

A new type of hearing aid is on the market which pairs ear buds with an AI-powered app. The app samples voices and creates speaker profiles, then allowing the user then to choose which voice they want to listen to and which to tune out.6

Why it matters: People with hearing loss now have a tool to address what’s called the “cocktail party problem,” where noisy environments make speech unintelligible. Indeed, hearing loss is a more prevalent issue than many might imagine: about 15% of Americans are affected by it.7 This use case for artificial intelligence can create an augmented and better reality for those Americans who currently have trouble operating in noisy spaces.



Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.